Trade concerns must not be allowed to set the public health agenda [2]

Lancet

Volumn 361, Issue 9351, 2003, Pages 71-72

  Ford, Nathan ^a   'T Hoen, Ellen ^a   McKee, Martin ^b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COMMERCIAL PHENOMENA; DRUG INDUSTRY; ECONOMIC ASPECT; EUROPE; HUMAN; INFECTION; LETTER; MALARIA; MEDICAL CARE; ORGANIZATION; PRIORITY JOURNAL; PUBLIC HEALTH; TUBERCULOSIS; UNITED STATES;

EID: 0037417476     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12123-X     Document Type: Letter

References (4)

1. World Trade Organization, Doha Ministerial Declaration on the TRIPS Agreement and Public Health. WTO document number WT/MIN(01)/DEC/2 (2001). Qatar: WTO, 2001.
2. Yudkin J.S. Insulin for the world's poorest countries. Lancet. 355:2000;919-921.
3. World Health Organization. Reducing Risks, Promoting Healthy Life. Geneva: WHO, 2002.
4. Editorial. Sleep less in Seattle. Lancet 1999; 354: 1917.